Article
A Clinically Silent Resistance Phenotype That Promotes <i>Acinetobacter baumannii</i> Survival During Colistin Therapy
2026-01-21
Abstract excerpt
Acinetobacter baumannii is a major cause of multidrug-resistant nosocomial infections, particularly ventilator-associated pneumonia, for which therapeutic options are increasingly limited. Colistin, a polymyxin antibiotic, is a drug of last resort for A. baumannii, boasting high susceptibility rates. Yet, despite relatively low rates of breakpoint-defined colistin resistance, clinical outcomes are highly variable...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 711cff2d-9443-5cdd-b44b-192b4f28a7f7
- DOI
- 10.64898/2026.01.20.700680
